4.7 Review

Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis

Journal

Publisher

MDPI
DOI: 10.3390/ijms22094479

Keywords

iron; biomarkers; ferroptosis; neurodegeneration; Alzheimer’ s disease

Funding

  1. University of Torino

Ask authors/readers for more resources

Proper functioning of all organs, including the brain, requires iron, which is present in different forms in biological fluids. Clinical parameters for monitoring iron concentration in biological fluids may not detect circulating iron accurately, while indirect measurements like magnetic resonance imaging need further validation.
Proper functioning of all organs, including the brain, requires iron. It is present in different forms in biological fluids, and alterations in its distribution can induce oxidative stress and neurodegeneration. However, the clinical parameters normally used for monitoring iron concentration in biological fluids (i.e., serum and cerebrospinal fluid) can hardly detect the quantity of circulating iron, while indirect measurements, e.g., magnetic resonance imaging, require further validation. This review summarizes the mechanisms involved in brain iron metabolism, homeostasis, and iron imbalance caused by alterations detectable by standard and non-standard indicators of iron status. These indicators for iron transport, storage, and metabolism can help to understand which biomarkers can better detect iron imbalances responsible for neurodegenerative diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available